A. Mcnicol et al., PHOSPHOLIPASE-C ACTIVITY IN PLATELETS FROM BERNARD-SOULIER SYNDROME PATIENTS, Arteriosclerosis and thrombosis, 13(11), 1993, pp. 1567-1571
The levels of glycoprotein (GP) Ib and GPV and phospholipase C activit
y were measured in platelets from three Bernard-Soulier syndrome patie
nts. The patients' platelets had 46%, 46%, and 24% of control levels o
f GPIbalpha and 43%, trace, and 13% of control levels of GPV as determ
ined by immunoblot analysis. Stimulation by thrombin, trypsin, the thr
omboxane analogue U46619, and the combination of U46619 and trypsin ca
used the formation of [P-32]phosphatidic acid, an index of phospholipa
se C activity, in [P-32] orthophosphate-prelabeled platelets. With all
agonists, however, the formation of [P-32] phosphatidic acid was mark
edly reduced in Bernard-Soulier syndrome platelets compared with contr
ol platelets. These data indicated a postreceptor defect in phospholip
ase C activation in Bernard-Soulier syndrome platelets and confirmed e
arlier observations of potential proteolytic and nonproteolytic mechan
isms of platelet activation.